Medherant

United Kingdom
Coventry, England, United Kingdom

Company profile

Medherant company profile

Medherant was founded by Professor David Haddleton and the University of Warwick to develop and commercialise novel transdermal drug delivery platforms. Current patch technologies have limited drug loading capabilities, making them unviable for use with many pharmaceutical products that could benefit from transdermal delivery. Creams and gels on the other hand suffer from a lack of dose control that is critical for many drugs.

Business identity

Contact email
[email protected]
Phone number
+442476323060
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$11.2M
Last funding
Series Unknown / $3.6M / 2023-04-03
Last equity funding
Series Unknown / $3.6M
Investors
2
Lead investors
2
Founders
1
Articles
3

Founders and investors

Founders

David Haddleton

Lead investors

Innovate UKMercia Asset Management

Investors

Innovate UKMercia Asset Management